Research on Targeted Botanicals for Breast Cancer
In my own clinical practice, I have seen remarkable results with breast cancer patients using a combination of targeted botanicals and integrative approaches. In fact it has been my experience that healing is greatly increased when women follow a synergistic path that strategically combines the best of both conventional and holistic treatments.
While standard modern medicine may struggle to provide long-term health options for women with serious breast cancer, there is good news from the natural health world that I am incredibly excited to share with you.
Triple Negative is the Deadliest Form of Breast Cancer
Triple negative breast cancer is the most aggressive and deadly type of breast cancer and carries a very high risk of early metastasis. Current treatment for triple negative breast cancer is extremely limited; and after conventional treatment many women have few viable options that can help them stay cancer free.
Groundbreaking Breast Cancer Formula Study
In a study conducted at the Cancer Research Laboratory, Methodist Research Institute, Indiana University Health, my botanically based Integrative Breast Formula has been shown to:
• Inhibit highly aggressive and deadly breast cancer metastasis
• Slow cancer growth
• Suppress cancer genes
• Offer safe and non-toxic support for breast and overall health
Breast Cancer Formula Study Results
The researchers demonstrated that this specialized formula slows highly aggressive triple negative human breast cancer and inhibits breast-to-lung metastasis in vivo. Using a model which mimics the clinical progression of triple negative breast cancer as it develops and metastasizes in patients, results showed that the formula significantly decreased tumor growth and breast-to-lung metastasis.
Formula Reduced Metastasis
The cancer metastasized to the lungs in only 20% of the treated group as compared to 67% of the untreated, control group. Therefore the formula significantly decreased incidence of breast to lung metastasis by 70%. Furthermore, in the treatment group that did metastasize, the number and size of the lesions was dramatically reduced in comparison to the control group.
Gene analysis showed that the formula down regulated (suppressed and reduced) two genes implicated in cancer metastasis — PLAU (urokinase plasminogen activator, uPA) and CXCR4 (C-X-C chemokine receptor-4). These results further substantiate previous cancer cell studies published on this formula, which similarly demonstrated a down regulation of these cancer promoting genes.
Biological Therapeutic Agent
“In this study we showed that the formula is not toxic and its oral application significantly suppresses tumor size, and dramatically inhibits breast-to-lung cancer metastasis,” says Daniel Sliva, Ph.D., lead author on the study. “This formula may be considered as a biological therapeutic agent against invasive breast cancer, including aggressive triple negative breast cancer. It can potentially increase survival of breast cancer patients who currently have limited or no treatment options available within conventional oncology.”
*The study (click to read) was presented at the prestigious annual meeting of the American Academy for Cancer Research and has just been published in the journal Oncology Reports. This is the third peer-reviewed study demonstrating the anticancer effects of this formula.
What do you think about this article? Please share your thoughts and experiences in the comments section below. We love to hear your feedback!